Use of rotigotine for treatment or prevention of dopaminergic neuron loss
    5.
    发明申请
    Use of rotigotine for treatment or prevention of dopaminergic neuron loss 审中-公开
    使用罗替戈汀治疗或预防多巴胺能神经元损失

    公开(公告)号:US20050197385A1

    公开(公告)日:2005-09-08

    申请号:US11060997

    申请日:2005-02-17

    IPC分类号: A61K31/381

    CPC分类号: A61K31/381

    摘要: The present patent application relates to the use of Rotigotine or its salts and prodrugs for preparation of a drug for treatment or prophylaxis of dopaminergic cell loss due to diseases that are connected with an increased dopaminergic cell loss. In particular, the patent application is related to the use of Rotigotine as a drug for preventive treatment of Morbus Parkinson.

    摘要翻译: 本专利申请涉及罗替戈汀或其盐和前药用于制备用于治疗或预防由于与多巴胺能细胞损失增加相关的疾病引起的多巴胺能细胞损失的药物的用途。 特别是,该专利申请涉及罗替戈汀作为Morbus帕金森预防性治疗药物的用途。